Jon J. Vernon

1.1k total citations
25 papers, 832 citations indexed

About

Jon J. Vernon is a scholar working on Infectious Diseases, Epidemiology and Periodontics. According to data from OpenAlex, Jon J. Vernon has authored 25 papers receiving a total of 832 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Infectious Diseases, 10 papers in Epidemiology and 5 papers in Periodontics. Recurrent topics in Jon J. Vernon's work include Clostridium difficile and Clostridium perfringens research (17 papers), Microscopic Colitis (10 papers) and Antimicrobial Resistance in Staphylococcus (6 papers). Jon J. Vernon is often cited by papers focused on Clostridium difficile and Clostridium perfringens research (17 papers), Microscopic Colitis (10 papers) and Antimicrobial Resistance in Staphylococcus (6 papers). Jon J. Vernon collaborates with scholars based in United Kingdom, Slovenia and Switzerland. Jon J. Vernon's co-authors include Mark H. Wilcox, Jane Freeman, K. Morris, Christopher Longshaw, Scott Nicholson, S. L. Todhunter, Monique J. T. Crobach, Ling Yuan Kong, Séverine Péchiné and Vivian G. Loo and has published in prestigious journals such as SHILAP Revista de lepidopterología, Clinical Microbiology Reviews and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Jon J. Vernon

25 papers receiving 825 citations

Peers

Countries citing papers authored by Jon J. Vernon

Since Specialization

Citations

This map shows the geographic impact of Jon J. Vernon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jon J. Vernon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jon J. Vernon more than expected).

Fields of papers citing papers by Jon J. Vernon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jon J. Vernon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jon J. Vernon. The network helps show where Jon J. Vernon may publish in the future.

Co-authorship network of co-authors of Jon J. Vernon

This figure shows the co-authorship network connecting the top 25 collaborators of Jon J. Vernon. A scholar is included among the top collaborators of Jon J. Vernon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jon J. Vernon. Jon J. Vernon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Molecular clock complexities of Clostridioides difficile 2025 ·Anaerobe ·Jon J. Vernon, David W. Eyre, M. H. Wilcox, Jane Freeman	1
2	Modulation of the Human Microbiome: Probiotics, Prebiotics, and Microbial Transplants 2025 ·Advances in experimental medicine and biology ·Jon J. Vernon	2
3	Antimicrobial susceptibility in Clostridioides difficile varies according to European region and isolate source 2024 ·JAC-Antimicrobial Resistance ·Jane Freeman, Virginie Viprey, (unknown), (unknown), Emma Clark, Jon J. Vernon, Warren N. Fawley, Georgina Davis, (unknown), Mark H. Wilcox, Maja Rupnik, Kerrie Davies, Marc J. M. Bonten, Ed J. Kuijper, (unknown), Evelina Tacconelli, Tuba Vilken, Nicola Petrosillo	1
4	Manipulating the diseased oral microbiome: the power of probiotics and prebiotics 2024 ·Journal of Oral Microbiology ·Xin Yu, Deirdre DeVine, Jon J. Vernon	18
5	Hemin availability induces coordinated DNA methylation and gene expression changes in Porphyromonas gingivalis 2023 ·mSystems ·Ricardo Costeira, (unknown), Jon J. Vernon, (unknown), Susan Joseph, Deirdre DeVine, Philip D. Marsh, Vardhman K. Rakyan, Michael A. Curtis, Jordana T. Bell	4
6	A point-prevalence study on community and inpatient Clostridioides difficile infections (CDI): results from Combatting Bacterial Resistance in Europe CDI (COMBACTE-CDI), July to November 2018 2022 ·Eurosurveillance ·Virginie Viprey, Georgina Davis, (unknown), (unknown), (unknown), Jon J. Vernon, Maja Rupnik, Alice Banz, (unknown), (unknown), (unknown), Mark H. Wilcox, Kerrie Davies	29
7	Increased Handpiece Speeds without Air Coolant: Aerosols and Thermal Impact 2022 ·Journal of Dental Research ·Jon J. Vernon, (unknown), Emma Black, Deirdre DeVine, Louise A. Fletcher, David J. Wood, Brian Nattress	5
8	Dental Mitigation Strategies to Reduce Aerosolization of SARS-CoV-2 2021 ·Journal of Dental Research ·Jon J. Vernon, Emma Black, (unknown), Deirdre DeVine, Louise A. Fletcher, David J. Wood, Brian Nattress	24
9	Antimicrobial resistance progression in the United Kingdom: A temporal comparison of Clostridioides difficile antimicrobial susceptibilities 2021 ·Anaerobe ·Jon J. Vernon, (unknown), Jane Freeman	16
10	Key Differences in Diagnosis and Patient Populations between Community and In-Patient <i>Clostridioides Difficile Infections</i> (CDI): Results from Combatting Bacterial Resistance in Europe CDI (COMBACTE-CDI) 2021 ·SSRN Electronic Journal ·Virginie Viprey, Georgina Davis, (unknown), (unknown), (unknown), Jon J. Vernon, Maja Rupnik, Alice Banz, Florence Allantaz, (unknown), (unknown), Mark H. Wilcox, Kerrie Davies	1
11	Immunomodulatory streptococci that inhibit CXCL8 secretion and NFκB activation are common members of the oral microbiota 2021 ·Journal of Medical Microbiology ·Sarah Myers, Thuy Do, Josephine Meade, Aradhna Tugnait, Jon J. Vernon, Jelena Pistolic, Robert E. W. Hancock, Philip D. Marsh, Harsh M. Trivedi, Guojun Chen, Deirdre DeVine	11
12	Five-year Pan-European, longitudinal surveillance of Clostridium difficile ribotype prevalence and antimicrobial resistance: the extended ClosER study 2019 ·European Journal of Clinical Microbiology & Infectious Diseases ·(unknown), Jane Freeman, Jon J. Vernon, (unknown), K. Morris, (unknown), (unknown), Emma Clark, José Palacios, Mark H. Wilcox	57
13	Investigating the transient and persistent effects of heat on Clostridium difficile spores 2019 ·Journal of Medical Microbiology ·(unknown), Jon J. Vernon, Jane Freeman, Mark H. Wilcox, C. H. Chilton	3
14	Investigating the effect of supplementation on Clostridioides (Clostridium) difficile spore recovery in two solid agars 2018 ·Anaerobe ·(unknown), Jon J. Vernon, Jane Freeman, Mark H. Wilcox, C. H. Chilton	4
15	Effect of fluoroquinolone resistance mutation Thr-82→Ile onClostridioides difficilefitness 2018 ·Journal of Antimicrobial Chemotherapy ·Jon J. Vernon, Mark H. Wilcox, Jane Freeman	12
16	The ClosER study: results from a three-year pan-European longitudinal surveillance of antibiotic resistance among prevalent Clostridium difficile ribotypes, 2011–2014 2017 ·Clinical Microbiology and Infection ·Jane Freeman, Jon J. Vernon, (unknown), K. Morris, Scott Nicholson, (unknown), Christopher Longshaw, Mark H. Wilcox	106
17	Efficacy of vancomycin extended-dosing regimens for treatment of simulatedClostridium difficileinfection within anin vitrohuman gut model 2016 ·Journal of Antimicrobial Chemotherapy ·G. S. Crowther, C. H. Chilton, Christopher Longshaw, S. L. Todhunter, (unknown), Jon J. Vernon, Andreas Karas, Mark H. Wilcox	13
18	Susceptibility of Clostridium difficile Isolates of Varying Antimicrobial Resistance Phenotypes to SMT19969 and 11 Comparators 2015 ·Antimicrobial Agents and Chemotherapy ·Jane Freeman, Jon J. Vernon, Richard Vickers, Mark H. Wilcox	24
19	In vitro susceptibility of Clostridium difficile to SMT19969 and comparators, as well as the killing kinetics and post-antibiotic effects of SMT19969 and comparators against C. difficile 2015 ·Journal of Antimicrobial Chemotherapy ·David F. Corbett, Andrew K. Wise, (unknown), Peter Warn, Simon D. Baines, G. S. Crowther, Jane Freeman, C. H. Chilton, Jon J. Vernon, Mark H. Wilcox, Richard Vickers	35
20	Pan-European longitudinal surveillance of antibiotic resistance among prevalent Clostridium difficile ribotypes 2014 ·Clinical Microbiology and Infection ·Jane Freeman, Jon J. Vernon, K. Morris, Scott Nicholson, S. L. Todhunter, Christopher Longshaw, Mark H. Wilcox	217

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact